×
Uh Oh! It looks like you may have forgotten a required element in your template. Please review the
highlighted selections.
×
Some optional elements have been omitted. You can delete this from the synoptic if you don't want to include it.
Procedure (select all that apply)
Excision
Parotidectomy, superficial
Parotidectomy, deep
Parotidectomy, total
Parotidectomy, not specified
Resection, submandibular gland
Resection, sublingual gland
Neck (lymph node) dissection
Other
Not specified
Tumor Site
Parotid gland, Superficial lobe
Parotid gland, Deep lobe
Parotid gland, Entire parotid gland
Submandibular gland
Sublingual gland
Other
Not specified
Tumor Laterality
Right
Left
Bilateral
Not specified
Tumor Focality
Unifocal
Multifocal
Cannot be determined
Tumor Size (cm)
Histologic Type
Mucoepidermoid carcinoma, low grade
Mucoepidermoid carcinoma, intermediate grade
Mucoepidermoid carcinoma, high grade
Adenoid cystic carcinoma, tubular pattern
Adenoid cystic carcinoma, cribriform pattern
Adenoid cystic carcinoma, solid pattern
Acinic cell carcinoma
Polymorphous adenocarcinoma, classic, low grade
Polymorphous adenocarcinoma, classic, intermediate grade
Polymorphous adenocarcinoma, classic, high grade
Polymorphous adenocarcinoma, cribriform (cribriform adenocarcinoma of salivary origin), low grade
Polymorphous adenocarcinoma, cribriform (cribriform adenocarcinoma of salivary origin), intermediate grade
Polymorphous adenocarcinoma, cribriform (cribriform adenocarcinoma of salivary origin), high grade
(Mammary analogue) Secretory carcinoma
Salivary duct carcinoma
Epithelial-myoepithelial carcinoma
(Hyalinizing) clear cell carcinoma
Adenocarcinoma, not otherwise specified, low grade
Adenocarcinoma, not otherwise specified, intermediate grade
Adenocarcinoma, not otherwise specified, high grade
Basal cell adenocarcinoma
Carcinosarcoma (true malignant mixed tumor)
Intraductal carcinoma, low grade
Intraductal carcinoma, high grade
Lymphoepithelial carcinoma
Myoepithelial carcinoma
Oncocytic carcinoma
Poorly differentiated carcinoma, small cell neuroendocrine
Poorly differentiated carcinoma, large cell neuroendocrine
Poorly differentiated carcinoma, undifferentiated
Sebaceous adenocarcinoma
Squamous cell carcinoma, primary
Carcinoma, type cannot be determined
Other histologic type
Preexisting Pleomorphic Adenoma Component
Not applicable
Present, Carcinoma ex pleomorphic adenoma, minimally invasive
Present, Carcinoma ex pleomorphic adenoma, invasive
Present, Carcinoma ex pleomorphic adenoma, intracapsular (noninvasive)
Present, Carcinoma ex pleomorphic adenoma, extent cannot be determined
High Grade Transformation
Not applicable
Not identified
Present
Macroscopic Tumor Extent
No evidence of extraparenchymal extension
Extraglandular soft tissue
Facial nerve
Skin
Ear canal
Mandible
Skull base
Pterygoid plates
Carotid artery encasement
Other (specify)
Cannot be determined
Lymphovascular Invasion
Not identified
Present
Cannot be determined
Perineural Invasion
Not identified
Present
Cannot be determined
Margins
Cannot be assessed
Uninvolved by carcinoma
Involved by carcinoma
Regional Lymph Nodes
Distant Site(s) Involved, if applicable
Not applicable
Lung
Bone
Brain
Liver
Other
Cannot be determined
Pathologic Staging (pTNM)
TNM Descriptors (select all that apply)
Not applicable
m
r
y
pT
pTX: Primary tumor cannot be assessed
pT0: No evidence of primary tumor
pTis: Carcinoma in situ
pT1: Tumor 2 cm or smaller in greatest dimension without macroscopic extraparenchymal extension
pT2: Tumor larger than 2 cm but not larger than 4 cm in greatest dimension without extraparenchymal extension
pT3: Tumor larger than 4 cm and/or tumor having macroscopic extraparenchymal extension
pT4a: Moderately advanced disease. Tumor invades skin, mandible, ear canal, and/or facial nerve.
pT4b: Very advanced disease. Tumor invades skull base and/or pterygoid plates and/or encases carotid artery
pN
A word about nodes
pNx: Regional lymph nodes cannot be assessed
pN0: No regional lymph node metastasis
pN1: Metastasis in a single ipsilateral lymph node, ENE(−), 3 cm or smaller in greatest
dimension
pN2a: Metastasis in single ipsilateral node 3 cm or smaller in greatest dimension and ENE(+)
pN2a: Metastasis in a single ipsilateral node larger than 3 cm but not larger than 6 cm in
greatest dimension and ENE(−)
pN2b: Metastasis in multiple ipsilateral nodes, none larger than 6 cm in greatest dimension and
ENE(−)
pN2c: Metastasis in bilateral or contralateral lymph node(s), none larger than 6 cm in greatest
dimension and ENE(−)
pN3a: Metastasis in a lymph node larger than 6 cm in greatest dimension and ENE(−)
pN3b: Metastasis in a single ipsilateral node larger than 3 cm in greatest dimension and
ENE(+)
pN3b: Metastasis in multiple ipsilateral, contralateral or bilateral nodes any with ENE(+)
pN3b: Metastasis in a single contralateral node of any size and ENE(+)
pM
pMx: Not applicable
pM1: Distant metastasis
+ Additional Pathologic Findings
None identified
Sialadenitis
Tumor associated lymphoid proliferation (TALP)
Other
Write Report